Adherence at the earliest stages of treatment is likely to be influenced by prior illness trajectories and future expectations, best captured (and addressed) before treatment begins. We examined the influence of illness trajectories and treatment expectations on psychosocial readiness to start antiretroviral therapy (ART) in Jinja, Uganda. In-depth interviews were conducted between October 2005 and April 2006 with 41 members of an AIDS support organisation on their first day of treatment. Transcribed texts were translated, coded and analysed thematically using NVIVO-7 software. Results indicated that acute fear of death and progressive withdrawal from social, economic and sexual roles narrowed focus on survival, while efficacy-enhancing experiences with septrin prophylaxis and trust in counsellors reinforced belief in HIV diagnosis and importance of adherence. Most enjoyed supportive home environments after disclosing their serostatus. Lack of money for food and transport was anticipated as the main barriers to future adherence, particularly among women. Integrating strong counselling support with ART provision helped channel the power of shared illness experience into positive motivation to adhere at the onset of treatment.
Introduction
Patient adherence to HIV medications is critical for the success of antiretroviral therapy (ART) programmes in Africa. Depending on the type of drug regimen used, sustained moderate to very high adherence is required to prevent treatment failure and the rise of drug resistance (Bangsberg, 2006) . Switching to secondline regimens is typically ten times or more expensive, adding to cost barriers for resource-poor settings (Global Price Reporting Mechanism on Antiretroviral Medicines, 2008) . A pooled analysis of recent adherence studies in North America found only 55% of recipients reported acceptable levels of adherence (Mills, Nachega, Buchan et al., 2006) . Some have questioned how this record can be improved upon in resource-poor settings with weak health infrastructure and minimal patient support (Gill, Hamer, Simon, Thea, & Sabin, 2005; Harries, Nyangulu, Hargreaves, Kaluwa, & Salaniponi, 2001 ).
While preliminary evidence suggested African populations adhere to ART as well if not better than their Western counterparts (Mills, Nachega, Buchan et al., 2006) , serious concerns remain (Jaffar, Munderi, & Grosskurth, 2008) . Most studies have been based on lifetime ART exposure of 6 months or less, often in the context of clinical trials where adherence tends to be better (Gill et al., 2005; Osterberg & Blaschke, 2005) , and have tended to ignore low retention rates observed in many programmes (Rosen, Fox, & Gill, 2007; Wakabi, 2008) . Little is known about long-term adherence in Africa or the reasons for unexpectedly strong adherence reported in many African studies to date.
Understanding the dynamic nature of adherence over time and treatment contexts, even for the same individuals, is critical to designing effective promotion efforts (Castro, 2005; Spire et al., 2002) . For example, adherence at the earliest stages of treatment is likely to be influenced by prior illness trajectories and future expectations, best captured (and addressed) before treatment begins. According to the health belief model which guided design and analysis of this study (Rosenstock, Strecher, & Becker, 1994) , determination to adhere at the outset of treatment will depend more on how individuals anticipate benefits of adherence before drugs have had a chance to work, balanced against anticipated health consequences of AIDS without treatment. Qualitative approaches are ideally suited for exploring such contextual influences (Sankar, Golin, Simoni, Luborsky, & Pearson, 2006) , but a general lack of studies employing longitudinal qualitative designs has been noted outside industrialised settings (Mills, Nachega, Bangsberg et al., 2006) . In this paper we present the design of a longitudinal qualitative study to document the experience of Ugandan trial participants over 3 years on ART. We further analyse qualitative data from baseline interviews conducted before treatment was initiated, to assess the general state of psychosocial readiness to begin lifelong therapy.
Methods
All study subjects were members of the Jinja branch of the AIDS Support Organisation (TASO) enrolled in a cluster-randomised trial integrated into normal health service delivery (Amuron et al., 2007) . TASO is a large non-governmental organisation with 11 centres in Uganda offering counselling, outpatient medical care, and a range of social support services to HIVinfected clients. They also conduct counsellor training, AIDS advocacy and community outreach (Ssebbanja, 2007) . It has been a pioneer in home-based AIDS care and the philosophy of 'living positively with AIDS' . This philosophy generally encourages optimism, acceptance, and openness with others about HIV status, especially within the household (Ssebbanja, 2007, p.11) . Group cohesiveness is actively promoted by invoking images of TASO as a 'family' (Ssebanja, 2007, p.9) , and shared identity tends to be strong. A typical challenge of interviewing TASO respondents is a tendency to underreport attitudes or experiences at odds with a positive living approach (locally known as the 'TASO' effect). The Jinja TASO clinic serves a predominantly poor rural and semi-urban population drawn from a radius of about 100 km. Most TASO clients earn less than $10 USD per month (about 30 cents per day), usually working as subsistence farmers. Few work in the formal sector for wages or salaries.
The primary aim of the larger trial is to compare the effectiveness of a home-based care strategy with health facility-based care in close-to-real-life conditions using quantitative methods. An independent qualitative study was nested inside the main trial.
It was designed to chronicle life changes and evolving challenges of adherence among a subsample of 40 trial participants over the first 3 years on ART, using intensive qualitative methods.
In-depth interviews were scheduled at the final enrolment visit before clients had started medication, and 3, 6, 18, and 36 months on ART. Home observation visits were conducted for all interviews after enrolment. The study is ongoing; in this paper we restricted analysis to baseline interview results alone. Prior to enrolment on ART, TASO routinely assessed all clients on clinical and psychosocial readiness during three orientation visits over a 4 -6-week period. Selection of a 'medicine companion' was mandatory, while disclosure to household members was strongly encouraged. For clients randomised to home-based care, visits took place at home where HIV testing and counselling could be offered to present household members. Facility-based clients were encouraged to invite household members to TASO for this service. The main objective of psychosocial screening was to educate and enable rather than exclude, and as failing eligibility criteria tended to delay ART initiation, psychosocial issues were addressed rather than denying treatment altogether. Outright exclusion on psychosocial grounds was rare.
Following the health belief model framework, respondents were asked about perceived susceptibility to AIDS death, perceived severity of non-adherence, and perceived barriers and benefits to adherence in the context of illness trajectories and treatment expectations. Baseline in-depth interview guides were developed based on two focus group discussions, each with TASO providers and ART clients enrolled before the trial began, respectively. Pretested guides were administered by experienced social science interviewers (two female and one male) trained to anticipate strong compliance bias by TASO study subjects grateful to be starting new medications. Sequential recruitment did not allow for matching interviewers and respondents by gender. Baseline interviews lasted about an hour, and covered illness and treatment histories, attitudes and understanding of ART, and expectations for the future. Tape-recorded interviews conducted in Luganda were later transcribed, translated and entered on computer by trained social science interviewers. Thematic coding was conducted by two analysts with the aid of NVIVO 7 software.
To ensure inter-coder reliability, analysts coded the first several interviews independently and compared their results. Notes and interview attributes were also entered into spreadsheet overviews to allow systematic comparisons across sample categories. Final consensus on themes was reached by discussion and debate between independent analysts and the principal investigator. and about half of the men (11/21) were widowed or separated. Socio-economic status was poor, consistent with general levels of poverty in the surrounding population. More than half had never completed primary education. Only five men and one woman ever held a salaried job; the rest had worked as farmers, small-scale traders or manual labourers prior to falling ill. 
Physical and emotional trajectories

Social and economic trajectories
The path to ART for most was marked by dual themes of withdrawal from normal work and social roles, and progressive dependence on immediate family members. Most had stopped or cut back on work as health conditions worsened. Similar reductions in social activity were mostly attributed to restricted mobility due to illness or lack of energy. Others deliberately withdrew because of self-consciousness about visible symptoms.
Aside from occasional finger pointing and labelling that most were quick to dismiss (at least in retrospect), no instances of enacted stigma from the outside community were reported: were entirely open, most chose to disclose only if they perceived some immediate benefit in doing so. Idle gossip was more of a concern than active stigma.
Expectations about ART and adherence
Expectations for life on ART were characterised by cautious optimism at the outset of treatment. Counsellors had warned participants to anticipate serious side-effects from medications, but most expected these to last 2 -3 months at most. All 
Discussion
Despite severe poverty, low levels of education, and limited access to health services (Amuron, 2007) , Ugandan study participants about to begin antiretroviral therapy expressed a high degree of psychosocial readiness to face the challenges of adherence that lay ahead. We believe this readiness was essentially authentic, reporting biases notwithstanding, when disaggregated into its component parts according to the Health Belief Model, which provided the theoretical framework for this study (Rosenstock et al., 1994) . In terms of perceived susceptibility, clients had (Mills, Nachega, Bangsberg et al., 2006; Vervoort, Borleffs, Hoepelman, & Mieke, 2007) (Bharat & Aggleton, 1999; Chimwaza & Watkins, 2004; Kipp, 2007; Seeley et al., 1993; Robson, 2000; Thomas, 2006 ) , their potential influence on adherence has never been addressed. Our findings suggest both may have actually enhanced psychosocial readiness for ART, by allowing participants to focus narrowly on survival with little to distract them from taking their medications. These findings highlight one of the recognised weaknesses of the Health Belief Model of ignoring the influence of social context on health behaviour. (Bajos, 1997; Van Campenhout, Cohen, Guizzardi, & Hausser, 1997) . Later generations of health behaviour models, most notably Bandura's social cognitive theory, have acknowledged that it is not only individual conviction but active social reinforcement that is most likely to yield sustainable behaviour change (Bandura, 1994; DiClemente & Peterson, 1994) . Such theories would predict that adherence reinforced by supportive social interaction would be higher and more sustainable than individually motivated mechanisms achieved in isolation.
The main barrier to adherence anticipated by study subjects was poverty itself, expressed primarily by women over lack of money to buy food or transport for monthly refills. It is worth noting that few if any of these participants would have afforded even the least expensive first-line regimens on their own. Similar concerns have been expressed by participants in the early stages of treatment in resource-poor settings (Au et al., 2006; Hardon et al., 2007; Kim & Farmer, 2006) , although the extent to which they interfere with long-term adherence after free drug provision remains to be seen. determination to adhere, perhaps the easiest to exaggerate, was similarly reported in a qualitative study of early ART recipients in Uganda (Crane et al., 2006) who went on to achieve over 80% adherence after 24 weeks on ART, despite drug supply interruptions and having to pay for their own medications (Oyugi et al., 2004) .
Given the history and resources an organisation like TASO has to offer its members, the level of psychosocial readiness observed here should not be generalised too broadly beyond this population. Nevertheless, predisposing factors such as exposure to AIDS deaths among family members or close friends, deference to medical authority, and the slow process of withdrawal and dependence are likely to be common features of HIV illness trajectories across other high-prevalence, low-resource settings.
To the extent that these contribute to psychosocial readiness, they may help explain better-than-expected early adherence rates documented in African populations with early access to ART. More attention towards the various and changing forms of social selection that influence access to new medications, for example Nguyen's study of West African confessional traditions akin to TASO's emphasis on status disclosure, would be useful for understanding adherence behaviour (Nguyen, Ako, Niamba, Sylla, & Tiendrébéogo, 2007) .
Only time and experience over the course of the trial will tell how psychosocial readiness expressed by these participants translates into actual adherence behaviour. Overall, these results would predict strong adherence in the initial stages of ART, but increasing challenges as time goes on, health improves and lives return to normal. Expanding roles and responsibilities might be expected to raise the effective cost of adherence, but also the capacity to meet those costs. Our results also highlight potential advantages of integrating ART provision with strong counselling and support services from the onset of treatment. 
